17-157 - AHEP0731 Treatment of Children with All Stages of Hepatoblastoma with Temsirolimus (IND#122782, NSC#683864) Added to High Risk Stratum Treatment A Phase III Study

Status: open

17-157 - AHEP0731 Treatment of Children with All Stages of Hepatoblastoma with Temsirolimus (IND#122782, NSC#683864) Added to High Risk Stratum Treatment A Phase III Study, An Intergroup Study for Participation by COG and the Japanese Study Group for

Treatment for Pediatric Oncology- Hepatoblastoma

Contact Us Or call 251-405-5121

Description

The primary goal of this study is to show that a risk-based treatment approach will maintain or improve EFS, decrease acute and long-term chemotherapy toxicity, and identify new agents for the treatment of children with hepatoblastoma. IRB 17-157

Providers Associated With This Trial

Principle Investigator

This link will open in a new tab or window.